课题基金 / 基金详情

SR Pro

SR Pro
SR专业版
批准号：
8934274
负责人：
TONY R. HUNTER
金额：
$20.76万
依托单位：
SALK INSTITUTE FOR BIOLOGICAL STUDIES
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-12-01 至 2018-11-30
来源：
https://reporter.nih.gov/project-details/8934274
关键词：
Amino AcidsCancer CenterCancer Center Support GrantCancer EtiologyCore FacilityDevelopmentFundingGenesIndividualMass Spectrum AnalysisPeptidesPhosphopeptidesPost-Translational Protein ProcessingProtein AnalysisProteinsProteomicsResource SharingResourcesServicesTranslatingmass spectrometermembersynthetic peptide

项目摘要

项目成果

TONY R. HUNTER的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质组学核心设施是在上一个资助期内与发展基金共同开发的资源。它在2008年的竞争性更新中被审查为既定核心，并获得了杰出绩效评估。该设施配备了两台质谱仪，使用质谱法为癌症中心的成员进行蛋白质组学分析。该设施的服务包括合成肽和磷酸肽的表征，蛋白质的鉴定和蛋白质修饰的分析。
英文摘要
The Proteomics Core Facility was developed as shared resource with Developmental funds in the previous funding period. It was reviewed as an established core in the 2008 competitive renewal and received an assessment of Outstanding Merit. The Facility, which is equipped with two mass spectrometers, performs proteomic analyses for members of the Cancer Center using Mass spectrometry. Services of the Facility include characterization of synthetic peptides and phosphopeptides, identification of proteins, and analysis of protein modifications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Biostatistics Core
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
Histidine phosphorylation as a new target for cancer therapy
海外基金